{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:18:19Z","timestamp":1790201899214,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/8\/3\/11\/2020\/ECD-I"],"award-info":[{"award-number":["5\/8\/3\/11\/2020\/ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/8\/3\/7\/2020\/ECD-1"],"award-info":[{"award-number":["5\/8\/3\/7\/2020\/ECD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research, Chandigarh","doi-asserted-by":"publisher","award":["IM\/24\/01-04-21-0012"],"award-info":[{"award-number":["IM\/24\/01-04-21-0012"]}],"id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research, Chandigarh","doi-asserted-by":"publisher","award":["IM\/24\/01\u201304\u201321\u20130012 dated 01\u201304\u20132021"],"award-info":[{"award-number":["IM\/24\/01\u201304\u201321\u20130012 dated 01\u201304\u20132021"]}],"id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jgar.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:13:40Z","timestamp":1697422420000},"page":"262-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2925-5608","authenticated-orcid":false,"given":"Seema","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-2989","authenticated-orcid":false,"given":"Tarun","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9848-591X","authenticated-orcid":false,"given":"Smrity","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6801-2155","authenticated-orcid":false,"given":"Keshav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Shilpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5736-1005","authenticated-orcid":false,"given":"Ayush","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-6134","authenticated-orcid":false,"given":"Sejal","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-8566","authenticated-orcid":false,"given":"Itu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7588-5903","authenticated-orcid":false,"given":"Mohd","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-542X","authenticated-orcid":false,"given":"Ranjana W.","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-0085","authenticated-orcid":false,"given":"Sunil","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.10.006_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.18-0256","article-title":"Kavita. Alternate anti-leprosy regimen for multidrug therapy refractory leprosy: a retrospective study from a tertiary care center in North India","volume":"100","author":"Narang","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2023.10.006_bib0002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.47276\/lr.85.3.177","article-title":"Drug resistance patterns in Mycobacterium leprae isolates from recurrenced leprosy patients attending The Leprosy Mission (TLM) Hospitals in India","volume":"85","author":"Lavania","year":"2014","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jgar.2023.10.006_bib0003","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.cmi.2015.08.004","article-title":"Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India","volume":"21","author":"Lavania","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2023.10.006_bib0004","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3201\/eid2408.180033","article-title":"Dapsone resistance in leprosy patients originally from American Samoa, United States, 2010-2012","volume":"24","author":"Williams","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.006_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.19-0390","article-title":"Evidence for Mycobacterium leprae drug resistance in a large cohort of leprous neuropathy patients from India","volume":"102","author":"Mahajan","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2023.10.006_bib0006","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","article-title":"Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315","volume":"24","author":"Cambau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2023.10.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02170-21","article-title":"Antimicrobial resistance among Leprosy patients in Brazil: real-world data based on the national surveillance plan","volume":"66","author":"Andrade","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.006_bib0008","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.2147\/IDR.S368682","article-title":"Molecular surveillance of antimicrobial resistance of Mycobacterium leprae from leprosy patients in Zhejiang Province. China","volume":"15","author":"Shi","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2023.10.006_bib0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0378-6323.152185","article-title":"Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India","volume":"81","author":"Hasanoor Reja","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/ced.12665","article-title":"Drug resistance in Mycobacterium leprae from patients with leprosy in China","volume":"40","author":"Liu","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0011","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jdermsci.2012.05.002","article-title":"Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in treatment-naive registered and recurrenced cases by molecular biological methods","volume":"67","author":"Mori","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jgar.2023.10.006_bib0012","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7883\/yoken.63.412","article-title":"Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico","volume":"63","author":"Matsuoka","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.006_bib0013","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2666-5247(22)00117-3","article-title":"Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study","volume":"3","author":"Marijke Braet","year":"2022","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.jgar.2023.10.006_bib0014","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/22221751.2019.1677177","article-title":"Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients","volume":"8","author":"Chokkakula","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jgar.2023.10.006_bib0015","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/cid\/ciz570","article-title":"Emergence and transmission of drug-\/multidrug-resistant Mycobacterium leprae in a former leprosy colony in the Brazilian Amazon","volume":"70","author":"Rosa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.006_bib0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jinf.2004.03.012","article-title":"Chae GT. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea","volume":"50","author":"You","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2023.10.006_bib0017","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4103\/idoj.idoj_599_21","article-title":"Drug resistance in Mycobacterium Leprae in the context of zero leprosy","volume":"12","author":"Singh","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jgar.2023.10.006_bib0018","unstructured":"World Health Organization. Anti-microbial resistance surveillance in leprosy: report of the virtual meeting. World Health Organization; 2021. Regional Office for South-East Asia. https:\/\/www.who.int\/publications\/i\/item\/SEA-GLP-7 [accessed 30.01.2023]"},{"key":"10.1016\/j.jgar.2023.10.006_bib0019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.25259\/IJDVL_915_2021","article-title":"Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: a prospective observational study from Northern India","volume":"89","author":"Singh","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12879-019-4100-6","article-title":"Underlying mechanisms of leprosy recurrence in the Western Amazon: a retrospective cohort study","volume":"19","author":"Gon\u00e7alves","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.006_bib0021","unstructured":"A guide for surveillance of antimicrobial resistance in leprosy: 2017 update. WHO. https:\/\/www.who.int\/publications\/i\/item\/9789290225492 [accessed 30.11.2021]."},{"key":"10.1016\/j.jgar.2023.10.006_bib0022","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.3390\/ijms232012443","article-title":"Drug resistance (dapsone, rifampicin, ofloxacin) and resistance-related gene mutation features in leprosy patients: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2023.10.006_bib0023","doi-asserted-by":"crossref","first-page":"370","DOI":"10.47276\/lr.93.4.370","article-title":"Molecular detection of drug resistance in clinical specimens of leprosy patients from a tertiary care leprosy centre in South India","volume":"93","author":"Muthusamy","year":"2022","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jgar.2023.10.006_bib0024","first-page":"36","article-title":"Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing\u2013a rapid tool for screening drug resistance in leprosy","volume":"82","author":"Sekar","year":"2011","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jgar.2023.10.006_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/ijdvl.IJDVL_34_16","article-title":"Resistance to anti leprosy drugs in multi-bacillary leprosy: a cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India","volume":"84","author":"Singh","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0026","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jgar.2022.06.008","article-title":"Ofloxacin resistance in multibacillary treatment-naive leprosy cases from Purulia, West Bengal\u202f: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases","volume":"30","author":"Ahuja","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2023.10.006_bib0027","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cmi.2021.07.007","article-title":"A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance","volume":"27","author":"Chauffour","year":"2021","journal-title":"Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.006_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.idnow.2022.04.001","article-title":"Drug resistance in leprosy\u202f: an update following 70 years of chemotherapy","volume":"52","author":"Aubry","year":"2022","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.jgar.2023.10.006_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ced.14884","article-title":"Equal rates of drug resistance in leprosy cases with recurrence and recurrent\/chronic type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?","volume":"47","author":"Narang","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0030","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.19-0905","article-title":"Multidrug-resistant Mycobacterium leprae in a case of smear-negative relapse","volume":"102","author":"Kamat","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2023.10.006_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0049475519884421","article-title":"Late reversal reaction with resistant Mycobacterium leprae: an emerging paradigm","volume":"50","author":"Sardana","year":"2020","journal-title":"Trop Doct"},{"key":"10.1016\/j.jgar.2023.10.006_bib0032","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/ijmy.ijmy_26_20","article-title":"Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications","volume":"9","author":"Sardana","year":"2020","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0033","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/jdv.18709","article-title":"A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in type 1 and type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions","volume":"37","author":"Muddebihal","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jgar.2023.10.006_bib0034","first-page":"ME05","article-title":"Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy","volume":"8","author":"Mehta","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jgar.2023.10.006_bib0035","first-page":"1","article-title":"Consumption of systemic antibiotics in India in 2019","volume":"4","author":"Koya","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.jgar.2023.10.006_bib0036","unstructured":"World Health Organization. Weekly epidemiological records. 2022;97:429\u201352."},{"key":"10.1016\/j.jgar.2023.10.006_bib0037","doi-asserted-by":"crossref","first-page":"96","DOI":"10.47276\/lr.93.2.96","article-title":"Safer and newer antimicrobial drugs for leprosy\u2013time to test monthly ROM in an adequately powered randomised trial?","volume":"93","author":"Lockwood","year":"2022","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jgar.2023.10.006_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.47276\/lr.94.1.89","article-title":"The perennial pursuit for an ideal anti-leprosy","volume":"94","author":"Dogra","year":"2023","journal-title":"Lepr Rev"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:01:15Z","timestamp":1761991275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S2213716523001753"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.10.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}